02648nam 22006374a 450 991080897130332120200520144314.01-280-50593-197866105059371-4175-1152-4600-00-0505-91-60129-449-2(CKB)1000000000243935(EBL)267519(OCoLC)191037964(SSID)ssj0000212530(PQKBManifestationID)11220826(PQKBTitleCode)TC0000212530(PQKBWorkID)10139766(PQKB)10768686(MiAaPQ)EBC267519(Au-PeEL)EBL267519(CaPaEBR)ebr10116446(CaONFJC)MIL50593(OCoLC)56051981(EXLCZ)99100000000024393520030423d2003 uy 0engur|n|---|||||txtrdacontentcrdamediacrrdacarrierNovel targets in breast disease /edited by Stan Lipkowitz1st ed.Amsterdam ;Washington, DC IOS Pressc20031 online resource (97 pages)"This is the book ed. of the journal Breast disease, vol. 15 (2002), issn 0888-6008"--T.p. verso.1-58603-355-7 Includes bibliographical references.Cover; Title page; Contents; Introduction; Targeting the estrogen receptor in clinical breast cancer; HER-2/Neu signaling and therapeutic approaches in breast cancer; Farnesyltransferase inhibitors: Potential therapeutic for inflammatory breast cancer?; Role of cell cycle control and cyclin-dependent kinases in breast cancer; Heat shock protein 90 is a rational molecular target in breast cancer; The proteasome as a novel target for the treatment of breast cancer; Apoptosis and the treatment of breast cancer; Immunologic targets for breast cancerThis work is devoted to therapies that take advantage of molecular targets relevant to breast cancer - so called novel molecular therapies. It presents a sampling of both old and new molecularly targeted therapies that are being developed.BreastDiseasesBreastCancerBreastCancerTreatmentBreastDiseases.BreastCancer.BreastCancerTreatment.616.99/44906Lipkowitz Stan1600606MiAaPQMiAaPQMiAaPQBOOK9910808971303321Novel targets in breast disease3923780UNINA